Source:http://linkedlifedata.com/resource/pubmed/id/13685503
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1961-12-1
|
| pubmed:keyword | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
OM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0016-450X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
52
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
73-82
|
| pubmed:dateRevised |
2008-6-3
|
| pubmed:meshHeading | |
| pubmed:year |
1961
|
| pubmed:articleTitle |
Influence of p-dimethylaminoazobenzene (DAB) pretreatment in neonatal stage on the DAB hepatocarcinogenesis in the adult rats, with special reference to sex difference in the carcinogenesis.
|
| pubmed:publicationType |
Journal Article
|